Wilbanks Smith & Thomas Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $598K | Sell |
|
|||||
|
2023
Q4 | $527K | Sell |
|
|||||
|
2023
Q3 | $546K | Sell |
|
|||||
|
2023
Q2 | $537K | Sell |
|
|||||
|
2023
Q1 | $549K | Buy |
|
|||||
|
2022
Q4 | $521K | Sell |
|
|||||
|
2022
Q3 | $465K | Sell |
|
|||||
|
2022
Q2 | $2.51M | Buy |
|
|||||
|
2022
Q1 | $2.45M | Buy |
|
|||||
|
2021
Q4 | $1.61M | Buy |
|
|||||
|
2021
Q3 | $1.14M | Buy |
|
|||||
|
2021
Q2 | $1.1M | Buy |
|
|||||
|
2021
Q1 | $831K | Buy |
|
|||||
|
2020
Q4 | $768K | Sell |
|
|||||
|
2020
Q3 | $793K | Sell |
|
|||||
|
2020
Q2 | $864K | Sell |
|
|||||
|
2020
Q1 | $855K | Buy |
|
|||||
|
2019
Q4 | $938K | Buy |
|
|||||
|
2019
Q3 | $648K | Sell |
|
|||||
|
2019
Q2 | $628K | Buy |
|
|||||
|
2019
Q1 | $605K | Buy |
|
|||||
|
2018
Q4 | $437K | Buy |
|
|||||
|
2018
Q3 | $273K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $276K | Buy |
|
|||||
|
2017
Q2 | $227K | Sell |
|
|||||
|
2017
Q1 | $284K | Sell |
|
|||||
|
2016
Q4 | $288K | Sell |
|
|||||
|
2016
Q3 | $339K | Buy |
|
|||||
|
2016
Q2 | $333K | Sell |
|
|||||
|
2016
Q1 | $325K | Sell |
|
|||||
|
2015
Q4 | $326K | Sell |
|
|||||
|
2015
Q3 | $350K | Buy |
|
|||||
|
2015
Q2 | $333K | Sell |
|
|||||
|
2015
Q1 | $439K | Sell |
|
|||||
|
2014
Q4 | $415K | Sell |
|
|||||
|
2014
Q3 | $472K | Sell |
|
|||||
|
2014
Q2 | $649K | Buy |
|
|||||
|
2014
Q1 | $621K | Sell |
|
|||||
|
2013
Q4 | $630K | Sell |
|
|||||
|
2013
Q3 | $660K | Buy |
|
|||||
|
2013
Q2 | $577K | Buy |
|